242 related articles for article (PubMed ID: 25402586)
1. Potential cytokine biomarkers in autism spectrum disorders.
Rose D; Ashwood P
Biomark Med; 2014; 8(9):1171-81. PubMed ID: 25402586
[TBL] [Abstract][Full Text] [Related]
2. Autism spectrum disorders: from immunity to behavior.
Careaga M; Ashwood P
Methods Mol Biol; 2012; 934():219-40. PubMed ID: 22933149
[TBL] [Abstract][Full Text] [Related]
3. Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders.
Suzuki K; Matsuzaki H; Iwata K; Kameno Y; Shimmura C; Kawai S; Yoshihara Y; Wakuda T; Takebayashi K; Takagai S; Matsumoto K; Tsuchiya KJ; Iwata Y; Nakamura K; Tsujii M; Sugiyama T; Mori N
PLoS One; 2011; 6(5):e20470. PubMed ID: 21647375
[TBL] [Abstract][Full Text] [Related]
4. Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank.
Abdallah MW; Larsen N; Mortensen EL; Atladóttir HÓ; Nørgaard-Pedersen B; Bonefeld-Jørgensen EC; Grove J; Hougaard DM
J Neuroimmunol; 2012 Nov; 252(1-2):75-82. PubMed ID: 22917523
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.
Ashwood P; Krakowiak P; Hertz-Picciotto I; Hansen R; Pessah I; Van de Water J
Brain Behav Immun; 2011 Jan; 25(1):40-5. PubMed ID: 20705131
[TBL] [Abstract][Full Text] [Related]
6. Immunological and autoimmune considerations of Autism Spectrum Disorders.
Gesundheit B; Rosenzweig JP; Naor D; Lerer B; Zachor DA; Procházka V; Melamed M; Kristt DA; Steinberg A; Shulman C; Hwang P; Koren G; Walfisch A; Passweg JR; Snowden JA; Tamouza R; Leboyer M; Farge-Bancel D; Ashwood P
J Autoimmun; 2013 Aug; 44():1-7. PubMed ID: 23867105
[TBL] [Abstract][Full Text] [Related]
7. Plasma cytokine profiling in sibling pairs discordant for autism spectrum disorder.
Napolioni V; Ober-Reynolds B; Szelinger S; Corneveaux JJ; Pawlowski T; Ober-Reynolds S; Kirwan J; Persico AM; Melmed RD; Craig DW; Smith CJ; Huentelman MJ
J Neuroinflammation; 2013 Mar; 10():38. PubMed ID: 23497090
[TBL] [Abstract][Full Text] [Related]
8. Peripheral and central inflammation in autism spectrum disorders.
Depino AM
Mol Cell Neurosci; 2013 Mar; 53():69-76. PubMed ID: 23069728
[TBL] [Abstract][Full Text] [Related]
9. [Research advances in immunological dysfunction in children with autism spectrum disorders].
Wang TT; DU L; Shan L; Jia FY
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Dec; 16(12):1289-93. PubMed ID: 25523585
[TBL] [Abstract][Full Text] [Related]
10. Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder.
Krakowiak P; Goines PE; Tancredi DJ; Ashwood P; Hansen RL; Hertz-Picciotto I; Van de Water J
Biol Psychiatry; 2017 Mar; 81(5):442-451. PubMed ID: 26392128
[TBL] [Abstract][Full Text] [Related]
11. The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder.
Masi A; Glozier N; Dale R; Guastella AJ
Neurosci Bull; 2017 Apr; 33(2):194-204. PubMed ID: 28238116
[TBL] [Abstract][Full Text] [Related]
12. Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders.
Abdallah MW; Larsen N; Grove J; Nørgaard-Pedersen B; Thorsen P; Mortensen EL; Hougaard DM
World J Biol Psychiatry; 2013 Sep; 14(7):528-38. PubMed ID: 22175527
[TBL] [Abstract][Full Text] [Related]
13. Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype?
Jyonouchi H; Geng L; Davidow AL
J Neuroinflammation; 2014 Oct; 11():187. PubMed ID: 25344730
[TBL] [Abstract][Full Text] [Related]
14. A pilot proteomic study of protein markers in autism spectrum disorder.
Ngounou Wetie AG; Wormwood K; Thome J; Dudley E; Taurines R; Gerlach M; Woods AG; Darie CC
Electrophoresis; 2014 Jul; 35(14):2046-54. PubMed ID: 24687421
[TBL] [Abstract][Full Text] [Related]
15. Altered T cell responses in children with autism.
Ashwood P; Krakowiak P; Hertz-Picciotto I; Hansen R; Pessah IN; Van de Water J
Brain Behav Immun; 2011 Jul; 25(5):840-9. PubMed ID: 20833247
[TBL] [Abstract][Full Text] [Related]
16. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment.
Goines PE; Ashwood P
Neurotoxicol Teratol; 2013; 36():67-81. PubMed ID: 22918031
[TBL] [Abstract][Full Text] [Related]
17. Autism in community pre-schoolers: developmental profiles.
Kantzer AK; Fernell E; Gillberg C; Miniscalco C
Res Dev Disabil; 2013 Sep; 34(9):2900-8. PubMed ID: 23816626
[TBL] [Abstract][Full Text] [Related]
18. Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study.
Zerbo O; Yoshida C; Grether JK; Van de Water J; Ashwood P; Delorenze GN; Hansen RL; Kharrazi M; Croen LA
J Neuroinflammation; 2014 Jun; 11():113. PubMed ID: 24951035
[TBL] [Abstract][Full Text] [Related]
19. Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder.
Masi A; Breen EJ; Alvares GA; Glozier N; Hickie IB; Hunt A; Hui J; Beilby J; Ravine D; Wray J; Whitehouse AJO; Guastella AJ
Mol Autism; 2017; 8():63. PubMed ID: 29214007
[TBL] [Abstract][Full Text] [Related]
20. Evidence supporting an altered immune response in ASD.
Mead J; Ashwood P
Immunol Lett; 2015 Jan; 163(1):49-55. PubMed ID: 25448709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
